Deuterated Atazanivir-D3-1

参考资料仅供科学研究，不可用于个人用途。

货号：BCP03513CAS号：1092540-56-1纯度：98%

在线咨询

购买咨询

全国免运费！免费咨询：400-099-8200 或手机联系：13472751340

* 必填项

请填妥以下表格,您将在一分钟内得到邮件机器人给你的报价。

* Required Fields.

Please complete the form below and we will contact you shortly.

* Required Fields.

Please complete the form below and we will contact you shortly.

CAS号	1092540-56-1	货号	BCP03513
中文名	Deuterated Atazanivir-D3-1
英文名	Deuterated Atazanivir-D3-1
中文别名
英文别名	CTP-518;CTP518;CTP 518;
SMILES
化学名称
分子式	C38H37D15N6O7	分子量	719.96
纯度	98%	配送	惯例下常温包邮
产品描述	Atazanivir-D3-2 is an azapeptide derivative and a HIV protease inhibitor. Atazanivir-D3-2 is a deuterium-containing agent. Atazanivir-D3-2 displays a shorter half life than atazanavir, as well as Atazanivir-D3-1 and Atazanivir-D3-3. Atazanavir sulfate prevents the formation of mature HIV virions in HIV-1 infected cells by selectively inhibiting the virus-specific processing of certain polyproteins (viral Gag and Gag-Pol). Atazanavir sulfate is currently approved for the treatment of HIV infection. Atazanavir is contraindicated for co-administration with medicines that are highly dependent on CYP3A for clearance and for which elevated plasma concentrations are associated with serious and/or life-threatening events. Due to inhibitory effects of atazanavir on CYP3A, CYP2C8, and UGTIAl, caution is advised when prescribing. Common adverse events associated with atazanavir include hyperbilirubinemia, rash, nausea, headache, mid jaundice/sclcral icterus.